Clinical trial
The Efficacy of Intravenous Ascorbic Acid in Patients With Severe Sepsis
NCT02734147 is registered in ClinicalTrials.gov with Christiana Care Health Services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Intravenous Ascorbic Acid in Patients With Severe Sepsis
- Lead sponsor
- Christiana Care Health Services
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 1, 2016
- Completion date
- November 23, 2017
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.